vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and HeartCore Enterprises, Inc. (HTCR). Click either name above to swap in a different company.

HeartCore Enterprises, Inc. is the larger business by last-quarter revenue ($3.0M vs $2.8M, roughly 1.1× DBV Technologies S.A.). HeartCore Enterprises, Inc. runs the higher net margin — 14.5% vs -1195.5%, a 1210.0% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs -81.6%). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs -5.2%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

HeartCore Enterprises, Inc. is a global SaaS provider specializing in customer experience management, digital transformation solutions, and marketing technology tools. It operates mainly in Japan, Asia-Pacific, and North America, serving small-to-medium businesses and large enterprises with content management systems, marketing automation platforms, and CRM solutions.

DBVT vs HTCR — Head-to-Head

Bigger by revenue
HTCR
HTCR
1.1× larger
HTCR
$3.0M
$2.8M
DBVT
Growing faster (revenue YoY)
DBVT
DBVT
+240.4% gap
DBVT
158.8%
-81.6%
HTCR
Higher net margin
HTCR
HTCR
1210.0% more per $
HTCR
14.5%
-1195.5%
DBVT
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
-5.2%
HTCR

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
DBVT
DBVT
HTCR
HTCR
Revenue
$2.8M
$3.0M
Net Profit
$-33.2M
$434.1K
Gross Margin
49.1%
Operating Margin
-1235.7%
-0.4%
Net Margin
-1195.5%
14.5%
Revenue YoY
158.8%
-81.6%
Net Profit YoY
-8.9%
-96.1%
EPS (diluted)
$-0.24
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
HTCR
HTCR
Q3 25
$2.8M
$3.0M
Q2 25
$1.5M
$4.7M
Q1 25
$3.6M
Q4 24
$-2.7M
Q3 24
$16.2M
Q2 24
$1.2M
$4.1M
Q1 24
$1.4M
$5.0M
Q4 23
$8.9M
$3.3M
Net Profit
DBVT
DBVT
HTCR
HTCR
Q3 25
$-33.2M
$434.1K
Q2 25
$-41.9M
$1.1M
Q1 25
$-3.1M
Q4 24
$-9.3M
Q3 24
$11.1M
Q2 24
$-33.1M
$-2.0M
Q1 24
$-27.3M
$-1.3M
Q4 23
$134.3M
$-2.9M
Gross Margin
DBVT
DBVT
HTCR
HTCR
Q3 25
49.1%
Q2 25
46.7%
Q1 25
30.7%
Q4 24
Q3 24
86.3%
Q2 24
19.8%
Q1 24
40.3%
Q4 23
2.9%
Operating Margin
DBVT
DBVT
HTCR
HTCR
Q3 25
-1235.7%
-0.4%
Q2 25
-2806.2%
2.3%
Q1 25
-34.7%
Q4 24
386.5%
Q3 24
76.0%
Q2 24
-2914.9%
-37.1%
Q1 24
-2029.7%
-13.5%
Q4 23
-134.3%
-95.1%
Net Margin
DBVT
DBVT
HTCR
HTCR
Q3 25
-1195.5%
14.5%
Q2 25
-2858.4%
23.2%
Q1 25
-86.1%
Q4 24
346.8%
Q3 24
68.1%
Q2 24
-2852.4%
-48.0%
Q1 24
-1943.5%
-26.4%
Q4 23
1512.8%
-85.7%
EPS (diluted)
DBVT
DBVT
HTCR
HTCR
Q3 25
$-0.24
$0.02
Q2 25
$-0.31
$0.04
Q1 25
$-0.14
Q4 24
$-0.45
Q3 24
$0.53
Q2 24
$-0.34
$-0.09
Q1 24
$-0.28
$-0.06
Q4 23
$-0.11
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
HTCR
HTCR
Cash + ST InvestmentsLiquidity on hand
$69.8M
$4.4M
Total DebtLower is stronger
$510.9K
Stockholders' EquityBook value
$52.9M
$5.2M
Total Assets
$110.5M
$13.3M
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
HTCR
HTCR
Q3 25
$69.8M
$4.4M
Q2 25
$103.2M
$2.5M
Q1 25
$2.3M
Q4 24
$6.5M
Q3 24
$8.6M
Q2 24
$66.2M
$4.2M
Q1 24
$101.5M
$1.6M
Q4 23
$141.4M
$1.7M
Total Debt
DBVT
DBVT
HTCR
HTCR
Q3 25
$510.9K
Q2 25
$1.5M
Q1 25
$1.5M
Q4 24
$545.1K
Q3 24
$1.9M
Q2 24
$1.9M
Q1 24
$2.0M
Q4 23
$2.2M
Stockholders' Equity
DBVT
DBVT
HTCR
HTCR
Q3 25
$52.9M
$5.2M
Q2 25
$86.2M
$4.8M
Q1 25
$1.8M
Q4 24
$4.7M
Q3 24
$12.4M
Q2 24
$79.1M
$1.6M
Q1 24
$111.7M
$3.9M
Q4 23
$140.2M
$5.2M
Total Assets
DBVT
DBVT
HTCR
HTCR
Q3 25
$110.5M
$13.3M
Q2 25
$143.4M
$13.5M
Q1 25
$10.2M
Q4 24
$14.0M
Q3 24
$25.5M
Q2 24
$114.2M
$24.1M
Q1 24
$145.9M
$22.3M
Q4 23
$183.0M
$19.6M
Debt / Equity
DBVT
DBVT
HTCR
HTCR
Q3 25
0.10×
Q2 25
0.31×
Q1 25
0.84×
Q4 24
0.12×
Q3 24
0.15×
Q2 24
1.20×
Q1 24
0.50×
Q4 23
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
HTCR
HTCR
Operating Cash FlowLast quarter
$-32.4M
Free Cash FlowOCF − Capex
$-32.6M
FCF MarginFCF / Revenue
-1173.5%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
HTCR
HTCR
Q3 25
$-32.4M
Q2 25
$-33.9M
$-674.1K
Q1 25
$-2.0M
Q4 24
$-1.3M
Q3 24
$-1.8M
Q2 24
$-35.1M
$-837.1K
Q1 24
$-34.7M
$-898.6K
Q4 23
$-13.7M
$-1.9M
Free Cash Flow
DBVT
DBVT
HTCR
HTCR
Q3 25
$-32.6M
Q2 25
$-33.9M
Q1 25
Q4 24
Q3 24
Q2 24
$-35.8M
Q1 24
$-36.0M
Q4 23
$-14.0M
$-1.9M
FCF Margin
DBVT
DBVT
HTCR
HTCR
Q3 25
-1173.5%
Q2 25
-2316.5%
Q1 25
Q4 24
Q3 24
Q2 24
-3084.0%
Q1 24
-2560.6%
Q4 23
-158.2%
-56.6%
Capex Intensity
DBVT
DBVT
HTCR
HTCR
Q3 25
4.2%
Q2 25
2.2%
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
63.0%
Q1 24
94.9%
Q4 23
4.0%
0.3%
Cash Conversion
DBVT
DBVT
HTCR
HTCR
Q3 25
Q2 25
-0.61×
Q1 25
Q4 24
Q3 24
-0.16×
Q2 24
Q1 24
Q4 23
-0.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DBVT
DBVT

Segment breakdown not available.

HTCR
HTCR

Customised Software Development And Services$1.7M58%
Software Related Cost Of Revenues$1.4M46%

Related Comparisons